Vassiliki Economides
Director of Finance/CFO at GRITSTONE BIO, INC.
Net worth: 200 764 $ as of 2024-04-29
Vassiliki Economides active positions
Companies | Position | Start | End |
---|---|---|---|
GRITSTONE BIO, INC. | Director of Finance/CFO | 2021-06-22 | - |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Director/Board Member | - | - |
Career history of Vassiliki Economides
Former positions of Vassiliki Economides
Companies | Position | Start | End |
---|---|---|---|
AURINIA PHARMACEUTICALS INC. | Investor Relations Contact | 2016-07-10 | 2019-02-28 |
Public Communications Contact | 2016-07-10 | 2019-02-28 | |
Corporate Officer/Principal | 2016-07-10 | 2019-02-28 | |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 2015-02-28 | 2016-05-31 |
KEZAR LIFE SCIENCES, INC. | Investor Relations Contact | 2019-03-03 | - |
Public Communications Contact | 2019-03-03 | - | |
PROSENSA HOLDING NV | Investor Relations Contact | - | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | - |
Training of Vassiliki Economides
McGill University | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Statistics
International
United States | 6 |
Canada | 4 |
Netherlands | 2 |
Operational
Investor Relations Contact | 4 |
Corporate Officer/Principal | 3 |
Public Communications Contact | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
AURINIA PHARMACEUTICALS INC. | Health Technology |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
KEZAR LIFE SCIENCES, INC. | Health Technology |
GRITSTONE BIO, INC. | Health Technology |
Private companies | 3 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Vassiliki Economides
- Experience